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Abstract
Background: Gene expression profiling by microarray analysis of cells enriched by laser capture
microdissection (LCM) faces several technical challenges. Frozen sections yield higher quality RNA
than paraffin-imbedded sections, but even with frozen sections, the staining methods used for
histological identification of cells of interest could still damage the mRNA in the cells. To study the
contribution of staining methods to degradation of results from gene expression profiling of LCM
samples, we subjected pellets of the mouse plasma cell tumor cell line TEPC 1165 to direct RNA
extraction and to parallel frozen sectioning for LCM and subsequent RNA extraction. We used
microarray hybridization analysis to compare gene expression profiles of RNA from cell pellets
with gene expression profiles of RNA from frozen sections that had been stained with hematoxylin
and eosin (H&E), Nissl Stain (NS), and for immunofluorescence (IF) as well as with the plasma cell-
revealing methyl green pyronin (MGP) stain. All RNAs were amplified with two rounds of T7-based
in vitro transcription and analyzed by two-color expression analysis on 10-K cDNA microarrays.
Results: The MGP-stained samples showed the least introduction of mRNA loss, followed by H&E
and immunofluorescence. Nissl staining was significantly more detrimental to gene expression
profiles, presumably owing to an aqueous step in which RNA may have been damaged by
endogenous or exogenous RNAases.
Conclusion: RNA damage can occur during the staining steps preparatory to laser capture
microdissection, with the consequence of loss of representation of certain genes in microarray
hybridization analysis. Inclusion of RNAase inhibitor in aqueous staining solutions appears to be
important in protecting RNA from loss of gene transcripts.
Background
Microarray hybridization has been used to study the glo-
bal gene expression from many different kinds of tissues
and cell lines [1-4]. When it is desired to apply this tech-
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sue, surrounded by cells of other types such as connective
tissue cells, it is essential to minimize the contribution of
mRNA from undesirable cells by enriching the percentage
of desirable cell types [5]. Laser Capture Microdissection
(LCM) is a valuable tool that makes this possible via the
visual (microscopic) identification of cells of interest in
intact tissues, followed by their excision and subsequent
RNA extraction and analysis by microarray hybridization
analysis [6-8]. Frozen sections are highly recommended to
maximize quantity and quality of RNA recovery [9,10].
However, in frozen sections it is often difficult to recog-
nize histological details after routine staining, such as
hematoxylin & eosin (H&E), in part because LCM requires
desiccated sections with no cover slip. Specialized staining
methods may be helpful for distinguishing cells of interest
from surrounding stroma, e.g., Nissl stain (NS), Immun-
ofluorescence (IF), and Immunohistochemistry (IHC)
[7,11,12], but these reagents potentially could result in
RNA damage. Methyl Green Pyronin (MGP) is a special
stain that has been useful in identifying plasma cells, a
major interest of this laboratory, owing to its staining of
the nucleus dark blue and the cytoplasm bright pink in
visible light or fluorescing red under UV illumination of
paraffin-imbedded sections [13]. Although MGP and all
histological stains yield significantly less detail on frozen
sections than on paraffin-embedded tissue, MGP did ena-
ble identification of plasma cells in the midst of other cell
types in oil granulomas (Figure 1B, panel c). Since the
pyronin reagent reacts with RNA, we worried that MGP
might damage the RNA and compromise the subsequent
gene expression profiling. Therefore, we investigated
whether MGP or other commonly used staining methods
themselves would affect gene expression profiling and to
what extent.
Usually, a minimum of 5–50 µg total RNA is required for
indirect or direct labeling of cDNA, respectively, with
fluorochromes such as Cy3 and Cy5 to perform hybridiza-
tion on one microarray chip to analyze gene expression
[14]. RNA yields of this magnitude are usually impossible
from the small number of cells that typically comprise
LCM-derived samples, requiring amplification to make
cDNA microarray analysis possible. RNA amplification by
RNA polymerase-based in vitro transcription is thought to
introduce the least bias to gene expression profiling [15-
17], although it is possible that amplifications methods
have the potential of amplifying the effect of damage to
mRNAs introduced during LCM processing.
It has not been determined to what extent each of the
steps in LCM sample processing damages the RNA, poten-
tially leading to loss of representation of certain genes
when amplified, reverse transcribed, labeled and hybrid-
ized to a microarray containing a wide spectrum of cDNA
targets on a glass slide. The purpose of the present study
was to assess how much the choice of histological staining
before LCM would contribute to gene loss, recognized as
dropout of hybridized spots, when compared with
unstained samples. To render our analysis statistically sig-
nificant we performed four biological replicates for each
Histochemical staining of frozen sections of an intraperito-neal primary mouse plasma cell tumorFigure 1
Histochemical staining of frozen sections of an intraperito-
neal primary mouse plasma cell tumor. A nodule rich in 
plasma cells can be seen in the midst of surrounding stromal 
and fat cells. The stains of the sections are as follows: H&E, 
hematoxylin and eosin; Nissl; MGP (methyl green pyronin) 
and kappa (immunoperoxidase in the top four panels or 
immunofluorescence in the bottom four panels) staining of 
immunoglobulin kappa light chains). The images in the top 
four panels represent frozen sections stained and mounted 
under cover slips in a distant histology laboratory and cap-
tured using high quality optics in a photographic studio. 
Those in the bottom four panels reflect the challenges of 
interpreting microscopic views on a microscope optimized 
for LCM, viewing frozen sections that had been processed 
and stained with the utmost speed to minimize RNA damage 
and lacking cover slips. Ovals indicate clusters of plasma cells 
with characteristic MGP staining and rich in Ig κ protein.Page 2 of 8
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derived tissue samples. Each of these 16 was compared
with a pool of RNA from an identical pellet of cells. We
found that the MGP staining method, which included
RNAase inhibitor, was the least detrimental to the RNA,
while the Nissl method, which had no RNAase inhibitor,
inflicted the most damage to the RNA.
Results
RNA was extracted from pellets of cultured TEPC 1165
murine plasma cell tumor cells, which had been flash fro-
zen immediately after harvest. LCM-derived RNA was iso-
lated from samples of microdissected frozen sections of
an identical cell pellet, which had been treated with differ-
ent staining methods. To obtain a sufficient amount of
total RNA from LCM-captured cells, we procured cells
with 2000–2500 hits of laser (approximately 4000–5000
cells in total). All LCM-captured samples yielded suffi-
cient total RNA (10 – 20 µg) that could be quantitated by
the low-range Ribogreen RNA Quantitation Kit (Molecu-
lar Probes). Each RNA sample was evaluated for suitability
for use by electrophoresis using Agilent RNA Pico chips.
RNA that was not degraded should have two clear bands
representing the 28S and 18S rRNA, with ratios of 28S/
18S absorbance exceeding 1.5. In addition, the RNA sam-
ple should be low in genomic DNA contamination, which
would appear as bands larger than 28S rRNA. RNA from
the unprocessed cell pellet had an acceptable 28S/18S
rRNA ratio of about 1.5. The four LCM samples also
showed clear 28 rRNA and 18 rRNA bands, but the 28S/
18S ratios were different: 1.75 for the unprocessed cell
pellet (A), 1.84 for MGP, 4.76 for H&E, 0.71 for NISSL,
2.05 for IF, indicating that a small amount of degradation
appeared in the Nissl RNAs (Figure 2) the only sample
with a ratio less than 1.7. The unusually high ratio on the
H&E lane appears to stem from the unusual and not yet
understood high background, since substantial amounts
of 28S are clearly visible to the naked eye. Five ng of total
RNA from all samples were subjected to 2 rounds of
amplification. All samples yielded sufficient amplified
antisense RNA for microarray hybridization. After two
rounds of amplification the total yield of antisense RNA
from all samples ranged from 40 µg to 60 µg. The size of
the antisense RNA after 2 rounds of amplification was in
the expected and satisfactory range between 200 NT to
700 NT for all the samples (data not shown), indicating
that these antisense RNAs could be used directly for cDNA
synthesis and probe labeling for microarray hybridiza-
tion. We did not perceive any consistent difference in
yield or size of amplified RNAs that could be attributed to
the method of staining.
Comparisons between LCM subgroups
We found significant differences between the molecular
profiles of each "LCM + staining" group and the unproc-
essed cell pellet (A). One-sample t-tests identified 74, 76,
108, and 77 genes differently expressed at the 0.001 sig-
nificance level between the unprocessed cell pellet and
MGP, H&E, NS and IF, respectively. Testing 8,534 probes
at this significance level, we expected that the average
number of spuriously significant (false positive) results
would be nine or less. Thus, the expression profiles in the
staining groups are significantly different from those of
the unprocessed cell pellet. Among these genes, 21, 44,
70, and 44 had at least 2-fold mean expression difference
for MGP, H&E, NS and IF, respectively (Table 1) of which
13, 29, 40, and 31 had lower expression. The heat map for
the union of the genes differentially expressed (p < 0.001
and ≥ 2-fold mean expression difference) between each
LCM + staining sample and the pool of cell pellet prepa-
rations (Figure 3) confirmed graphically that the MGP
staining method introduced the fewest differences. The
MGP vs. A comparison in the 4 left-most columns showed
Analysis of RNA qualityFigure 2
Analysis of RNA quality. One ng of total RNA from one sam-
ple from each staining group was electrophoresed on Agilent 
Bioanalyzer system (Pico RNA chip). RNA ladder 6000 
(Ambion, Inc). Lane A contains total RNA from unsectioned 
cell pellets. Lanes marked MGP, H&E, NS and IF indicate the 
staining method used before LCM procurement and RNA 
preparation. Lowermost band (green) in all lanes is an Agilent 
alignment marker.
Ladder  A MGP HE  NS  IF 
18S 
28S 
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loss nor gain of signal following staining.
In addition, we tested the difference in expression profiles
among the H&E, NS, IF samples and the MGP samples
(Table 2). The number of genes significant at the 0.001
level and with a mean expression difference greater than
2-fold is equal to 61, 147, and 112 for H&E, NS and IF,
respectively. Most of these genes (52, 115, and 89 for
H&E, NS and IF, respectively) had weaker signals in these
three groups of samples, compared with the MGP-stained
group, suggesting loss of signal at additional spots, owing
to RNA damage acquired during staining. The global per-
mutation tests also showed that the overall signals in the
H&E, NS and IF samples were significantly weaker than in
the MGP samples (p-values <0.02).
Loss of mRNA suitable for hybridizing to some of the
cDNAs was the result expected from damage during
processing, and this loss was expected to show no gene
specificity. The accuracy of this prediction can be visually
appreciated in the heat maps presented in Figure 3. Thus,
no additional analysis was done to analyze which specific
genes were involved in expression changes among the
individual chips.
Superimposed upon this experimentally induced spot
drop out are the differences inherent in the microarray
hybridization method. The number of spots that show
increased intensities (always lower than the number of
spots with decreased intensities) may be a rough measure
of this effect in each subgroup. Thus, we subtracted this
value form the number of spots with lower intensities in
the stained samples to yield a value that can be used for
inter-group comparison.
Discussion
The cDNA microarray hybridization method is now
widely used to analyze simultaneously the expression of
thousands of genes in cancer tissues [5,21], but the con-
tamination of tumors by epithelial, stromal or immune
cells presents problems for obtaining accurate expression
profiles. Microarray analysis coupled with LCM is a good
way to solve this problem. However, cDNA microarray
analysis requires a large amount of total RNA (5 µg to 100
Table 2: Number of spots differently hybridizing after staining 
with stains other than MGP.
Intensity Ratios H&E/MGP NS/MGP IF/MGP
Total number 61 147 112
2-fold lower 52 115 89
2-fold higher 9 32 23
Net lower 43 83 66
Shown are numbers of genes with greater than two-fold change in 
expression when means of each group, e.g., H&E-stained, LCM-
procured cells, were compared with the gene expression profile of 
the MGP-stained, LCM-procured RNA. Net genes lower was 
calculated as total genes lower minus the number higher.
Log-ratios of genes significantly different between A (cell pel-let) and LCM samples where genes are sorted according to the or er f a dendrogram generated by clust ring ov r genesFi u e 3
Log-ratios of genes significantly different between A (cell pel-
let) and LCM samples where genes are sorted according to 
the order of a dendrogram generated by clustering over 
genes. Red shades correspond to higher expression in the 
staining group than A; green shades correspond to lower 
expression; and black indicates no difference.
MGP H&E NS IF
1 2 3 41 2 3 4 1 2 3 4 1 2 3 4
-2 -1 0 1 2
log base 2
Table 1: Number of genes significantly differently expressed (p < 
0.001 and > 2-fold mean expression difference) after LCM and 
staining.
Intensity Ratios MGP/A H&E/A NS/A IF/A
Total number 21 44 70 44
2-fold lower 13 29 40 31
2-fold higher 8 15 30 13
Net lower 5 14 10 18
Shown are numbers of genes with greater than two-fold change in 
expression when means of each group, e.g., MGP-stained, LCM-
procured cells, were compared with the gene expression profile "A" 
from the pelleted, unstained sample (not LCM-procured). Net genes 
lower was calculated as total genes lower minus the number higher.Page 4 of 8
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cation can be used reliably, without compromising RNA
quality or gravely skewing patterns of gene expression,
when only small initial amounts of total RNA are availa-
ble [16,17,22]. In this study, we used two rounds of
amplification to obtain amounts of antisense RNA suffi-
cient for microarray hybridization yielding strong signal
intensities, permitting statistical data processing.
To positively identify the specific cells desired for the
microdissection, a staining protocol must be used, which
permits identification of plasma cells in desiccated cryo-
sections. Such sections, without cover slips, are required
for microdissection and may pose a critical problem, since
desiccate cryosections are not optically ideal for histolog-
ical examination (cf. Figure 1). However, staining solu-
tions may react with cellular components, such as RNA,
potentially adversely affecting RNA integrity. In addition,
the aqueous components of the staining reagents may
contain or activate intracellular RNAases and result in
RNA degradation. For this reason, it was important to test
different conditions for tissue staining and section dehy-
dration to assure high quality of RNA from LCM samples.
To assure ourselves of adequate numbers of uniform pop-
ulations of plasma cells, which are scarce in most tissues,
we utilized pellets of cultured plasma cell tumor cells that
were sectioned and stained as if they had been collected
by LCM. We used this approach, because obtaining large
enough sample of plasma cell tumor cells from tissues by
LCM would have been impracticable.
Our modification (addition of RNAase inhibitor) to the
standard MGP staining method has made it suitable for
use with LCM. Sections treated as described here can be
used to prepare total RNA of good quality. Though
pyronin is a fluorescent molecule that can bind to RNA,
we detected only 21 changes when compared with
unstained LCM samples. This amounted to less than 0.3%
of the analyzed microarray elements, and less than one
half of the number changed due to the other staining
methods tested.
It appears that inclusion of RNAase inhibitor in staining
solutions can prevent RNA from damage by endogenous
and exogenous RNAase. The Nissl-stained group was the
only staining protocol that did not include RNAase inhib-
itor. The number of genes in this group with 2-fold
changes, 70 spots, was the highest among all four groups,
indicating that this staining procedure damaged the most
mRNAs.
In summary, we performed a statistical analysis of 16
cDNA microarray chips comparing fluorescent-labeled
cDNA generated from amplified RNA from 16 independ-
ently isolated and processed, LCM-procured, stained fro-
zen sections with amplified RNA from an identical pellet
of plasma cell tumor cells. This showed that a variable
amount of spot fall-out was seen after staining of the fro-
zen sections, depending on the staining method, indicat-
ing that the choice of staining method can be important
in minimizing loss of mRNAs from microarray analysis of
LCM-derived RNA. Happily, the degree of mRNA damage
was small with the commonly used H&E method, so long
as RNAase inhibitor was included in the aqueous hema-
toxylin solution. Nissl staining solution, which may not
be compatible with RNAase inhibitor addition, intro-
duced the greatest degree of damage. Fortunately, for our
ongoing study of plasma cell tumor development, the
MGP stain, chosen for its unique ability to flag plasma
cells in tissue sections, was the least destructive of all. Our
analysis suggests that maximizing the use of non-aqueous
staining solutions is recommended for other specialty
stains that might be advantageous for identification of
other cell types in studies that require use of LCM. The
inclusion of RNAase inhibitor in aqueous solutions
appears to be important in rendering histological staining
procedures suitable to extraction of intact RNA.
Conclusion
RNA damage can occur during the staining steps prepara-
tory to laser capture microdissection, resulting in loss of
representation of certain genes in microarray hybridiza-
tion analysis. Inclusion of RNAase inhibitor in aqueous
staining solutions appears to be important in protecting
RNA from loss of gene transcripts.
Methods
Cell culture
The murine plasma cell tumor cell line TEPC 1165 [18]
was used both as a source of frozen sections for LCM as
well as a source of reference RNA, i.e., RNA extracted with-
out LCM processing. Cells were grown in RPMI 1640
media supplemented with 10% fetal bovine serum, 10 ng/
ml IL-6, 4 mM L-glutamine and 100 units/ml penicillin
and 100 units/ml streptomycin. Duplicate cell pellets
were collected by low-speed centrifugation in 50-ml coni-
cal centrifuge tubes and immediately snap frozen for RNA
extraction and LCM preparation.
Preparation of LCM samples
The cell pellets were frozen in a dry ice-ethanol bath,
embedded with OCT frozen tissue embedding medium,
and stored at -80°C. Six-micrometer serial frozen sections
were cut on a cryostat at -20°C and mounted on chilled,
pre-cleaned, uncoated microscope glass slides that had
been heated at 200°C overnight to eliminate RNAase.
Slides were kept on dry ice or at -80°C until LCM was
completed. Sections were stained individually with four
different methods before LCM. RNAase-free (treated with
diethylpyrocarbonate) water was used for all solutions.Page 5 of 8
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unless otherwise stated, and usually on the same day as
the frozen sectioning.
Methyl Green Pyronin staining
After fixation in 70% ethanol (10 sec), each slide was
rinsed in DEPC-treated water (5 sec). Then, 50 µl of MGP
staining solution (Sigma/Aldrich) to which RNAase
inhibitor (SUPERase*In, Ambion) had been added to a
final concentration of 500 U/ml, was applied to the sec-
tion and incubated 2 min, followed by a quick dip in
diethylpyrocarbonate-treated water, dehydration in 100%
ethanol in 2 steps (quick dip, then for 10–15 sec), and
xylenes in 2 steps (2 min then 3 min). It is important to
note that MGP, like all histological stains, yields signifi-
cantly less detail on frozen sections than on paraffin-
embedded tissue, in part, owing to lack of a cover slip.
MGP did enable identification of plasma cells in oil gran-
ulomas under these conditions. To be used in this way,
however, one must include RNAase inhibitor if RNA
extraction is desired after LCM.
Hematoxylin and eosin staining
A modification was incorporated into the manufacturer's
(Sigma/Aldrich) protocol; namely, RNAase inhibitor
(SUPERase*In, Ambion) was added to the aqueous hema-
toxylin solution to a final concentration of 500 U/ml.
Briefly, slides were stained as follows: 70% EtOH for 10
sec, DEPC-treated water for 5 sec, hematoxylin with
RNAase inhibitor for 20 sec, 70% EtOH for 30 sec, eosin
Y in 100% EtOH for 20 sec, followed by dehydration with
a series of alcohol for 30 sec each, and xylenes for 2 min.
Nissl staining
The frozen sections were fixed with 70% ethanol (30 sec),
rinsed in DEPC-treated water (30 sec), immersed in NS
staining solution (Arcturus Corp.) for 30 sec, dehydrated
with graded alcohols (30 sec each) and xylenes (2 min
and 3 min).
Immunofluorescence
Sections were fixed in ice-cold acetone for 2 min, rinsed in
DEPC-treated PBS for 10 sec, incubated with a 1:250 dilu-
tion of goat anti-mouse Igκ conjugated with TXRD
(Southern Biotechnology Associates, Inc.) to which
RNAase inhibitor (SUPERase*In, Ambion) had been
added to a final concentration of 500 U/ml, for 2 min in
the dark, dehydrated with 100% ethanol and xylenes
(11).
Laser capture microscopy
Cells were lifted from the slide onto CapSure LCM plastic
caps (Arcturus Corp.) using a 30-µm spot size of laser at
the power of 50 µv using PixCell II LCM system (Arcturus
Corp.).
RNA extraction and purification
Total RNA from the unprocessed cell pellet was extracted
using TriZol reagent (Sigma), treated with RNAase-free
DNAase I (Qiagen, Inc.), followed by RNA purification
with Qiagen RNeasy kit according to the manufacturer's
protocol. RNA concentration was measured spectropho-
tometrically.
RNA extraction of 16 LCM-derived samples (4 from each
staining group) was performed with the PicoPure RNA
extraction kit (Arcturus Corp.), simultaneously treated
with RNAase-free DNAase I (Qiagen, Inc) according to the
manufacturer's protocol. Briefly, 50 µl of extraction buffer
was pipetted onto the tissue fragments that had been col-
lected in the cap of a sterile plastic 1.5-micro-centrifuge
tube (CapSure LCM caps, Arcturus Corp.), and they were
incubated together in a hot-air oven at 42°C for 30 min.
Cells and buffer were collected by centrifugation at 800 ×
g for 2 min. RNA was DNAase-treated and purified on a
preconditioned RNA-purification spin column according
to the manufacturer's recommendations. LCM-derived
total RNA was quantitated with Ribogreen (Molecular
Probes, Inc.) using Victor 2 1420 multilabel counter (Per-
kin-Elmer/Wallac). To assess the RNA quality and confirm
the absence of genomic DNA contamination, the Agilent
2100 Bioanalyzer (Pico RNA chip) was used to perform
electrophoresis on picogram amounts of total RNA. Only
samples with intact 18S and 28S rRNA peaks were used for
gene expression analysis.
RNA amplification
We performed antisense RNA amplification of each RNA
sample with RiboAmp™ RNA Amplification kit (Arcturus,
Inc.) based on T7 RNA polymerase in vitro transcription of
cDNA synthesized by reverse transcription primed by
oligo-dT attached to the T7 RNA polymerase promoter
[15]. To avoid bias caused by different starting amounts of
total RNA in the amplification process, 5 ng of total RNA
were used in all experimental and reference samples. To
obtain sufficient antisense RNA for microarray experi-
ments, two rounds of amplification were performed on all
samples. The total yield of amplification products was
determined using Ribogreen (Molecular Probes, Inc.),
and the sizes of the amplified RNAs were determined with
the Agilent Bioanalyzer (nano RNA chip).
Probe labeling and cDNA array hybridization
Probes were synthesized and labeled from 4 µg of ampli-
fied RNA (aRNA) by the method of Xiang et al [14]. In
brief, 4 µg of amplified RNA were combined with 4 µg
amine-modified random primer and 5 units of RNAase
inhibitor (SUPERase*In, Ambion). The mixture was incu-
bated at 70°C for 10 min, then chilled on ice for 10 min,
and left at room temperature for 10 min. Primer-RNA
solution was added to the reverse transcriptase mixPage 6 of 8
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0.2 mM aminoallyl-dUTP) and incubated at 42°C for 2 h.
The reaction was terminated by adding 10 µl 0.5 M EDTA,
and RNA was hydrolyzed with 10 µl 1 M NaOH at 65°C
for 30 min. The solution was neutralized with 10 µl 1 M
HCl, and then MinElute PCR purification kits (Qiagen,
Inc) were used to purify the cDNAs. The cDNA was eluted
three times with 10 µl of H2O. In each staining group 3 of
the 4 reference RNA samples were labeled with Cy5, while
1 of the 4 was labeled with Cy3. Three of each group of 4
experimental samples were labeled with Cy3, and 1 of 4
was labeled with Cy5 to test for bias from labeling. Probes
were mixed and hybridized overnight at 42°C in hybridi-
zation solution (New England Nuclear) to microarray
chips with a total of 9998 cDNA elements (InCyte)
printed by the NCI microarray facility.
Evaluation of gene-specific dye bias
Four arrays were hybridized for each of the 4 groups
(MGP, HE, IF, NS). In each group 3 arrays had cDNA
derived from the reference, unsectioned pellet of cells
labeled with Cy5 and the LCM-derived test sample labeled
with Cy3, and one array had the labeling reversed. We
were interested in evaluating the possibility of gene-spe-
cific dye bias that was not removed by the normalization
process. To evaluate this possibility, we computed the
average difference in log2 ratio between normalized for-
ward- and reverse-label experiments for each array ele-
ment as an estimate of the residual dye bias for the
associated gene. Of the 8534 array elements, none had an
average difference of log2 ratio in absolute value greater
than 1 (i.e., 2-fold difference). Thus, we concluded that
after normalization there was no systematic bias favoring
either dye.
Array scanning and data processing
Arrays were scanned at 10-µm resolution using a GenePix
4000 (Axon Inc.) array scanner. PMT voltages were varied
to gain optimum intensity of the spots. Four duplicate
hybridizations/slides were used in each experiment. LCM-
derived RNAs were regarded as "experimental" samples,
and 3 of the 4 cDNA probes derived from them were
labeled with Cy3, whereas the "reference" samples,
derived from RNA from unprocessed cell pellets were usu-
ally labeled with Cy5. To rule out color bias produced by
the labeling process itself, the fluorochromes were
reversed once in each group of four repeats. Quantifica-
tion files were obtained by using the GenePixPro 4.0 soft-
ware (Axon Inc.). The fluorescence signal intensity was
determined as the volume in a fixed-size circle, and back-
ground was estimated as the median pixel value in a dia-
mond-shaped region between each adjacent four-spot
region.
Data filtering and normalization
Log-ratios of local median background-subtracted inten-
sity levels were analyzed. For each array element, if the
intensity was less than 75 in one channel but greater than
75 in the other channel, the intensity <75 was set at 75.
Array elements that were flagged as poor quality during
image analysis or that had intensities less than 75 in both
channels were not reliable and treated as missing [19]. Six
percent of the array elements were found to be missing in
this way. Those samples with missing values for a particu-
lar array element were excluded from all analyses involv-
ing that array element. In order to have enough samples
in each group to compare expression profiles between the
groups, array elements were further filtered out and
removed from analysis if their number of non-missing
values in each group was less than three. Eleven percent of
the array elements were filtered out in this way, resulting
in 8534 array elements for analysis. Log-ratios for each
microarray were normalized by the locally robust lowess
smoother (20) to adjust for any dye bias and variation in
PMT voltage settings.
Clustering
Average linkage hierarchical analysis of differentially
expressed genes was performed by using 1-Pearson corre-
lation as the distance metric to group genes based on their
patterns of variation across the staining groups. The clus-
ters and associated heat maps were implemented in R.
Enumeration of differentially expressed genes
Identification of array elements that were differentially
expressed between each subgroup and the reference sam-
ple and among subgroups was done using one-sample t-
tests and two-sample t-tests, respectively. Differentially
expressed genes were identified as those genes that were
significant at the 0.001 level (p < 0.001) and which were
at least 2-fold different in the geometric mean of the
expression measurements. A treated subgroup was consid-
ered to have weaker expression than another treated sub-
group if, among the genes that were differentially
expressed between these two subgroups, it had more
lower-expressed genes than higher-expressed genes. A glo-
bal permutation test was used as a global test to assess if
one subgroup had statistically significant weaker expres-
sion than the other subgroup. Specifically, two-sample t-
tests were performed by randomly permuting the group
labels. In each permutation, the difference between the
number of lower-expressed genes and the number of
higher-expressed genes was recorded. The p-value of the
permutation test was the proportion of permutations with
the same or larger difference as those observed in the orig-
inal data. Two subgroups would be defined as having glo-
bally significant different expression profiles if the p-value
from the permutation test is less than 0.05.Page 7 of 8
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LCM (Laser Capture Microdissection), MGP (Methyl
Green Pyronin), H&E (Hematoxylin and Eosin), NS
(Nissl Stain), IF (Immunofluorescence).
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